This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by KANNEL, W. B. Articles by DAWBER, T. R. Search for Related Content PubMed PubMed Citation Articles by KANNEL, W. B. Articles by DAWBER, T. R.

(Stroke. 1974;5:679.)
© 1974 American Heart Association, Inc.

---

Role of Lipids in the Development of Brain Infarction: The Framingham Study

WILLIAM B. KANNEL M.D.¹; TAVIA GORDON ¹; THOMAS R. DAWBER M.D.²

¹ Framingham Heart Disease Epidemiology Study, Framingham, Massachusetts 01701 (supported by NHLI, NIH, Bethesda, Maryland)
² Boston University Medical Center, Boston. Massachusetts

An association of blood lipids with the development of atherothrombotic brain infarction under age 60 is demonstrated. This is based on 18 years' surveillance of 5,209 men and women, of whom 52 men and 59 women developed brain infarction. The relationship under age 60 was statistically significant only for men.

Triglyceride-rich pre-beta and cholesterol-rich beta lipoprotein were both related to the incidence of premature brain infarctions. Regardless of associated lipoprotein pattern, risk was proportional to serum cholesterol value, under age 60. On the other hand, pre-beta lipoprotein was unrelated to risk when associated cholesterol was taken into account.

At any lipid value risk of brain infarction varied greatly depending on the number and intensity of other contributors. Blood lipids are best considered as an ingredient of a stroke profile, and in the absence of other contributors to risk the influence of lipid is feeble.

Key Words: age • risk factors • stroke incidence • cerebrovascular disease

This article has been cited by other articles:

				N. Koren-Morag, D. Tanne, E. Graff, U. Goldbourt, and for the Bezafibrate Infarction Prevention Study Gr Low- and High-Density Lipoprotein Cholesterol and Ischemic Cerebrovascular Disease: The Bezafibrate Infarction Prevention Registry Arch Intern Med, May 13, 2002; 162(9): 993 - 999. [Abstract] [Full Text] [PDF]

				K.-L. Chien, F.-C. Sung, H.-C. Hsu, T.-C. Su, R.-S. Lin, and Y.-T. Lee Apolipoprotein A-I and B and Stroke Events in a Community-Based Cohort in Taiwan: Report of the Chin-Shan Community Cardiovascular Study Stroke, January 1, 2002; 33(1): 39 - 44. [Abstract] [Full Text] [PDF]

				J F Albucher, J Ferrieres, J B Ruidavets, B Guiraud-Chaumeil, B P Perret, and F Chollet Serum lipids in young patients with ischaemic stroke: a case-control study J. Neurol. Neurosurg. Psychiatry, July 1, 2000; 69(1): 29 - 33. [Abstract] [Full Text] [PDF]

				R. L. Rogers, J. S. Meyer, K. McClintic, and K. F. Mortel Reducing Hypertriglyceridemia in Elderly Patients with Cerebrovascular Disease Stabilizes or Improves Cognition and Cerebral Perfusion Angiology, April 1, 1989; 40(4): 260 - 269. [Abstract] [PDF]